Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for fatigue in primary biliary cholangitis
ISRCTN03978701Phase 2Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Oct 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2, randomised, double-blind trial in primary biliary cholangitis (PBC) comparing Rituximab with Placebo (2 arms). Primary endpoint: Fatigue severity and quality of life. Started Oct 2012; status: completed.
02
Drugs
rituximab
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on ISRCTN03978701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN03978701.